首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

1291344

血紅蛋白病市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Hemoglobinopathies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年05月29日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2022年，全球血紅蛋白病的市場規模達到92億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到163億美元，在2023-2028年期間表現出9.39%的成長率（CAGR）。

血紅蛋白病是促使血紅蛋白分子結構和生產異常的遺傳性血液疾病。鐮狀細胞、地中海貧血、血紅蛋白C和BETA-地中海貧血是一些常見的血紅蛋白病類型。血紅蛋白病可通過基因檢測、高效液相色譜法檢測血紅蛋白、常規紅細胞（RBC）計數、血紅蛋白等電聚焦（Hb IEF）和血紅蛋白電泳（Hb ELP）試驗來檢測。皮膚蒼白、呼吸急促、手腳冰涼、疲倦、疼痛、手腳腫脹是血紅蛋白病的幾個最常見的症狀。一些廣泛使用的血紅蛋白病治療方案包括抗生素、ACE抑製劑、幹細胞移植、輸血、羥基脲和止痛劑。

血紅蛋白病的市場趨勢：

鐮狀細胞病（SCD）和地中海貧血症等各種病症的發病率越來越高，是推動市場成長的關鍵因素之一。血紅蛋白病是由異常的血紅蛋白引起的，它使紅細胞變形和損壞，並使紅細胞變硬和粘稠。與此相呼應，貧血患病率的上升，特別是在老年人口中，也容易受到各種其他慢性疾病的影響，有利於市場的成長。各種技術進步，如CRISPR-Cas9技術的發展，通過編輯、刪除、添加或改變基因和修改DNA來治療血紅蛋白病，正在為市場成長提供動力。與此相呼應，廣泛採用基因療法治療血紅蛋白病有利於市場成長。其他因素，如醫療保健行業的大幅擴張，以及政府實施各種計劃促進研究和開發（R&D）活動，以可承受的成本推出治療血紅蛋白病的新型療法，預計將為市場提供積極的前景。

紅血球(RBC)計數
- 市場趨勢
- 市場預測
基因檢測
- 市場趨勢
- 市場預測
高效液相色譜法（HPLC）
- 市場趨勢
- 市場預測
血紅蛋白等電聚焦法（Hb IEF)
- 市場趨勢
- 市場預測
血紅蛋白電泳(Hb ELP)
- 市場趨勢
- 市場預測
血紅蛋白溶解度測試
- 市場趨勢
- 市場預測

第九章：按終端用戶分類的市場

醫院和診所
- 市場趨勢
- 市場預測
診斷學實驗室
- 市場趨勢
- 市場預測
其他
- 市場趨勢
- 市場預測

第十章：按地區分類的市場

北美洲
- 美國
  - 市場趨勢
  - 市場預測
- 加拿大
  - 市場趨勢
  - 市場預測
亞太地區
- 中國
  - 市場趨勢
  - 市場預測
- 日本
  - 市場趨勢
  - 市場預測
- 印度
  - 市場趨勢
  - 市場預測
- 韓國
  - 市場趨勢
  - 市場預測
- 澳大利亞
  - 市場趨勢
  - 市場預測
- 印尼
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
歐洲
- 德國
  - 市場趨勢
  - 市場預測
- 法國
  - 市場趨勢
  - 市場預測
- 英國
  - 市場趨勢
  - 市場預測
- 義大利
  - 市場趨勢
  - 市場預測
- 西班牙
  - 市場趨勢
  - 市場預測
- 俄羅斯
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
拉丁美洲
- 巴西
  - 市場趨勢
  - 市場預測
- 墨西哥
  - 市場趨勢
  - 市場預測
- 其他國家
  - 市場趨勢
  - 市場預測
中東和非洲
- 市場趨勢
- 按國家分類的市場
- 市場預測

第十一章：SWOT分析

概述
優勢
劣勢
機會
威脅

第十二章：價值鏈分析

第十三章：波特五力分析

概述
買方的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第十四章：價格分析

第十五章：競爭格局

市場結構
主要參與者
主要參與者的概況
- Bio-Rad Laboratories Inc.
- bluebird bio Inc.
- Bristol-Myers Squibb Company
- Danaher Corporation
- Emmaus Life Sciences Inc.
- Gamida-Cell Ltd.
- Global Blood Therapeutics Inc.
- Novartis AG
- PerkinElmer Inc.
- Pfizer Inc.
- Prolong Pharmaceuticals LLC
- Sangamo Therapeutics Inc.
- Sysmex Corporation

簡介目錄圖表

Product Code: SR112023A5123

The global hemoglobinopathies market size reached US$ 9.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.39% during 2023-2028.

Hemoglobinopathies is genetic blood disorder that causes structural and production abnormalities in hemoglobin molecules. Sickle cell, thalassemia, hemoglobin C, and beta-thalassemia are some of the common types of hemoglobinopathies. Hemoglobinopathies are detected by genetic testing, hemoglobin by high-performance liquid chromatography, routine red blood cell (RBC) count, hemoglobin isoelectric focusing (Hb IEF), and hemoglobin electrophoresis (Hb ELP) test. Pale skin, shortness of breath, cold hands or feet, tiredness, pain, and swelling in the hands and feet are a few of the most common symptoms hemoglobinopathies. Some of the widely used hemoglobinopathies treatment solutions include antibiotics, ACE inhibitors, stem-cell transplantation, blood transfusions, hydroxyurea, and analgesic.

Hemoglobinopathies Market Trends:

The increasing prevalence of various medical conditions, such as sickle cell disease (SCD) and thalassemia, is one of the key factors driving the growth of the market. Hemoglobinopathies are caused by abnormal hemoglobin that deforms and damages red blood cells and makes them hard and sticky. In line with this, the rising prevalence of anemia, especially among the geriatric population, which is also susceptible to various other chronic ailments, is favoring the market growth. Various technological advancements, such as the development of CRISPR-Cas9 technology to cure hemoglobinopathies by editing, removing, adding, or altering genes and modifying the DNA, are providing an impetus to the market growth. In line with this, the widespread adoption of gene therapy for the treatment of hemoglobinopathy is favoring market growth. Other factors, such as the significant expansion in the healthcare industry, along with the implementation of various government initiatives to promote research and development (R&D) activities to introduce novel therapies for treating hemoglobinopathies at affordable costs is anticipated to provide a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hemoglobinopathies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment, test type and end user.

Breakup by Type:

Thalassemia

Alpha Thalassemia

Beta Thalassemia

Sickle Cell Disease

Others

Breakup by Treatment:

Hemoglobinopathies Market Trends:

Key Market Segmentation:

Breakup by Type:

Thalassemia

Alpha Thalassemia

Beta Thalassemia

Sickle Cell Disease

Others

Breakup by Treatment:

Blood Transfusion

Stem-cell Transplantation

Analgesics

Antibiotics

ACE Inhibitors

Hydroxyurea

Others

Breakup by Test Type:

Red Blood Cell (RBC) Count

Genetic Testing

High Performance Liquid Chromatography (HPLC)

Hemoglobin Isoelectric Focusing (Hb IEF)

Hemoglobin Electrophoresis (Hb ELP)

Hemoglobin Solubility Test

Breakup by End User:

Hospitals and Clinics

Diagnostics Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., bluebird bio Inc., Bristol-Myers Squibb Company, Danaher Corporation, Emmaus Life Sciences Inc., Gamida-Cell Ltd., Global Blood Therapeutics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Prolong Pharmaceuticals LLC, Sangamo Therapeutics Inc. and Sysmex Corporation.

Key Questions Answered in This Report

1. What was the size of the global hemoglobinopathies market in 2022?

2. What is the expected growth rate of the global hemoglobinopathies market during 2023-2028?

3. What has been the impact of COVID-19 on the global hemoglobinopathies market?

4. What are the key factors driving the global hemoglobinopathies market?

5. What is the breakup of the global hemoglobinopathies market based on the type?

6. What is the breakup of the global hemoglobinopathies market based on the treatment?

7. What are the key regions in the global hemoglobinopathies market?

8. Who are the key players/companies in the global hemoglobinopathies market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Hemoglobinopathies Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Thalassemia
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Alpha Thalassemia
  - 6.1.2.2 Beta Thalassemia
- 6.1.3 Market Forecast
6.2 Sickle Cell Disease
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Treatment

7.1 Blood Transfusion
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Stem-cell Transplantation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Analgesics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Antibiotics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 ACE Inhibitors
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Hydroxyurea
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by Test Type

8.1 Red Blood Cell (RBC) Count
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Genetic Testing
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 High Performance Liquid Chromatography (HPLC)
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Hemoglobin Isoelectric Focusing (Hb IEF)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Hemoglobin Electrophoresis (Hb ELP)
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Hemoglobin Solubility Test
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Diagnostics Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Bio-Rad Laboratories Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 bluebird bio Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bristol-Myers Squibb Company
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Danaher Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Emmaus Life Sciences Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 Gamida-Cell Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
- 15.3.7 Global Blood Therapeutics Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 Novartis AG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 PerkinElmer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Prolong Pharmaceuticals LLC
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Sangamo Therapeutics Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Sysmex Corporation
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Hemoglobinopathies Market: Major Drivers and Challenges
Figure 2: Global: Hemoglobinopathies Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Hemoglobinopathies Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Hemoglobinopathies Market: Breakup by Type (in %), 2022
Figure 5: Global: Hemoglobinopathies Market: Breakup by Treatment (in %), 2022
Figure 6: Global: Hemoglobinopathies Market: Breakup by Test Type (in %), 2022
Figure 7: Global: Hemoglobinopathies Market: Breakup by End User (in %), 2022
Figure 8: Global: Hemoglobinopathies Market: Breakup by Region (in %), 2022
Figure 9: Global: Hemoglobinopathies (Thalassemia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Hemoglobinopathies (Thalassemia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Hemoglobinopathies (Sickle Cell Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Hemoglobinopathies (Sickle Cell Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Hemoglobinopathies (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Hemoglobinopathies (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Hemoglobinopathies (Blood Transfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Hemoglobinopathies (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Hemoglobinopathies (Stem-cell Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Hemoglobinopathies (Stem-cell Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Hemoglobinopathies (Analgesics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Hemoglobinopathies (Analgesics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Hemoglobinopathies (Antibiotics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Hemoglobinopathies (Antibiotics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Hemoglobinopathies (ACE Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Hemoglobinopathies (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Hemoglobinopathies (Hydroxyurea) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Hemoglobinopathies (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Hemoglobinopathies (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Hemoglobinopathies (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Hemoglobinopathies (Red Blood Cell (RBC) Count) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Hemoglobinopathies (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Hemoglobinopathies (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Hemoglobinopathies (High Performance Liquid Chromatography-HPLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Hemoglobinopathies (Hemoglobin Isoelectric Focusing-Hb IEF) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Hemoglobinopathies (Hemoglobin Electrophoresis-Hb ELP) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Hemoglobinopathies (Hemoglobin Solubility Test) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Hemoglobinopathies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Hemoglobinopathies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Hemoglobinopathies (Diagnostics Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Hemoglobinopathies (Diagnostics Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Hemoglobinopathies (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Hemoglobinopathies (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: North America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: North America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: United States: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: United States: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Canada: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Canada: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Asia-Pacific: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Asia-Pacific: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: China: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: China: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Japan: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Japan: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: India: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: India: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: South Korea: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: South Korea: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Australia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Australia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Indonesia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Indonesia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Europe: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Europe: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Germany: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Germany: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: France: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: France: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: United Kingdom: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: United Kingdom: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Italy: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Italy: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Spain: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Spain: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Russia: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Russia: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Latin America: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Latin America: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Brazil: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Brazil: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Mexico: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Mexico: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Others: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Others: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Middle East and Africa: Hemoglobinopathies Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Middle East and Africa: Hemoglobinopathies Market: Breakup by Country (in %), 2022
Figure 95: Middle East and Africa: Hemoglobinopathies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Global: Hemoglobinopathies Industry: SWOT Analysis
Figure 97: Global: Hemoglobinopathies Industry: Value Chain Analysis
Figure 98: Global: Hemoglobinopathies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Hemoglobinopathies Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Hemoglobinopathies Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Hemoglobinopathies Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
Table 4: Global: Hemoglobinopathies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 5: Global: Hemoglobinopathies Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Hemoglobinopathies Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Hemoglobinopathies Market: Competitive Structure
Table 8: Global: Hemoglobinopathies Market: Key Players

02-2729-4219

+886-2-2729-4219